{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20120471,Language='FR')/Transcripts"}},"ID":20120471,"Language":"FR","BusinessShortNumber":"12.471","BusinessType":4,"BusinessTypeName":"Initiative parlementaire","BusinessTypeAbbreviation":"Iv. pa.","Title":"M\u00e9dicaments. Proroger une nouvelle fois les autorisations cantonales","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>Conform\u00e9ment \u00e0 l'art.\u00a0160, al.\u00a01, de la Constitution et \u00e0 l'article 107 de la loi sur le Parlement, je d\u00e9pose l'initiative parlementaire suivante\u00a0:</p><p>L'article 95, Dispositions transitoires, de la loi sur les produits th\u00e9rapeutiques (LPTh) sera modifi\u00e9 comme suit\u00a0:</p><p>Art. 95</p><p>...</p><p>Al. 2</p><p>Les autorisations cantonales de m\u00e9dicaments sont valables jusqu'au 31 d\u00e9cembre 2017.</p><p>...</p>","ReasonText":"<p>Lors de la premi\u00e8re \u00e9tape de la r\u00e9vision de la LPTh, la validit\u00e9 des autorisations cantonales de m\u00e9dicaments a \u00e9t\u00e9 prolong\u00e9e jusqu'au 31 d\u00e9cembre 2013 (art. 95 LPTh). La deuxi\u00e8me \u00e9tape de la r\u00e9vision ordinaire de la LPTh pr\u00e9voit un r\u00e9gime d\u00e9finitif pour les autorisations cantonales. On ne sait pas encore quelle forme le Parlement donnera \u00e0 ce r\u00e9gime. Il est en tout cas peu vraisemblable qu'il adopte les nouvelles normes avant le 31 d\u00e9cembre 2013, date \u00e0 laquelle la validit\u00e9 des autorisations cantonales expirera, d'autant plus que les d\u00e9bats commenceront au plus t\u00f4t au cours du premier trimestre 2013. Ces normes, de toute \u00e9vidence, ne pourront donc pas entrer en vigueur le 1er janvier 2014. Pour \u00e9viter que les fabricants soumis \u00e0 autorisation cantonale ne se trouvent dans une situation d'ins\u00e9curit\u00e9 juridique, il faut prolonger une nouvelle fois la validit\u00e9 des autorisations cantonales. </p><p>Si l'on ne modifiait pas la LPTh afin de proroger ces autorisations, la commercialisation des m\u00e9dicaments cantonaux deviendrait ill\u00e9gale \u00e0 partir du 1er janvier 2014. Certains de ces produits feraient in\u00e9vitablement leur apparition sur le march\u00e9 noir, qui \u00e9chappe par d\u00e9finition au contr\u00f4le des autorit\u00e9s, et la s\u00e9curit\u00e9 des m\u00e9dicaments s'en trouverait s\u00e9rieusement compromise.</p>","DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":null,"FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":null,"SubmittedBy":"Gilli Yvonne","BusinessStatus":229,"BusinessStatusText":"Liquid\u00e9","BusinessStatusDate":"\/Date(1371772800000)\/","ResponsibleDepartment":null,"ResponsibleDepartmentName":null,"ResponsibleDepartmentAbbreviation":null,"IsLeadingDepartment":null,"Tags":"2841","Category":null,"Modified":"\/Date(1770758745720)\/","SubmissionDate":"\/Date(1348704000000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Conseil national","SubmissionCouncilAbbreviation":"CN","SubmissionSession":4905,"SubmissionLegislativePeriod":49,"FirstCouncil1":1,"FirstCouncil1Name":"Conseil national","FirstCouncil1Abbreviation":"CN","FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"Sant\u00e9"}}